These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 1701450

  • 1. An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule.
    Doyle LA, Borges M, Hussain A, Elias A, Tomiyasu T.
    J Clin Invest; 1990 Dec; 86(6):1848-54. PubMed ID: 1701450
    [Abstract] [Full Text] [Related]

  • 2. Expression of neuroendocrine and epithelial markers in an adherent subline derived from a classic small cell lung cancer cell line.
    Walker C, Wright-Perkins S.
    Oncol Res; 1992 Dec; 4(10):419-29. PubMed ID: 1337994
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF, Campbell SE, Bochner BS, Dang CV.
    Cancer Res; 1998 Dec 01; 58(23):5537-45. PubMed ID: 9850091
    [Abstract] [Full Text] [Related]

  • 6. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
    Watanabe H, Takahashi T, Ueda R, Utsumi KR, Sato T, Ariyoshi Y, Ota K, Obata Y, Takahashi T.
    Cancer Res; 1988 May 01; 48(9):2544-9. PubMed ID: 2833350
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule.
    Scheidegger EP, Lackie PM, Papay J, Roth J.
    Lab Invest; 1994 Jan 01; 70(1):95-106. PubMed ID: 8302024
    [Abstract] [Full Text] [Related]

  • 8. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
    Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, Schlegel J, Suske G, Schuermann M.
    Oncogene; 2002 Dec 12; 21(57):8683-95. PubMed ID: 12483521
    [Abstract] [Full Text] [Related]

  • 9. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
    Doyle LA, Mabry M, Stahel RA, Waibel R, Goldstein LH.
    Br J Cancer Suppl; 1991 Jun 12; 14():39-42. PubMed ID: 1645569
    [Abstract] [Full Text] [Related]

  • 10. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
    van Waardenburg RC, Meijer C, Pinto-Sietsma SJ, de Vries EG, Timens W, Mulder NM.
    Anticancer Res; 1998 Jun 12; 18(1A):91-5. PubMed ID: 9568061
    [Abstract] [Full Text] [Related]

  • 11. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
    Arvelo F, Poupon MF, Le Chevalier T.
    Anticancer Res; 1994 Jun 12; 14(5A):1893-901. PubMed ID: 7847823
    [Abstract] [Full Text] [Related]

  • 12. Identification and characterisation in vitro of cells with a non-SCLC cell-like phenotype derived from a continuous SCLC cell line.
    Khan MZ, Freshney RI, Murray AM, Merry S, Plumb JA, McNicol AM.
    Anticancer Res; 1991 Jun 12; 11(5):1687-95. PubMed ID: 1662924
    [Abstract] [Full Text] [Related]

  • 13. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
    Gazdar AF, Carney DN, Nau MM, Minna JD.
    Cancer Res; 1985 Jun 12; 45(6):2924-30. PubMed ID: 2985258
    [Abstract] [Full Text] [Related]

  • 14. Detection of cytoskeletal proteins in small cell lung carcinoma.
    Hlozánková M, Lukás Z, Viklický V.
    Gen Physiol Biophys; 1999 Dec 12; 18 Suppl 1():47-9. PubMed ID: 10707834
    [Abstract] [Full Text] [Related]

  • 15. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212.
    Moolenaar CE, Muller EJ, Schol DJ, Figdor CG, Bock E, Bitter-Suermann D, Michalides RJ.
    Cancer Res; 1990 Feb 15; 50(4):1102-6. PubMed ID: 2153450
    [Abstract] [Full Text] [Related]

  • 16. The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies.
    Olabiran Y, Ledermann JA, Marston NJ, Boxer GM, Hicks R, Souhami RL, Spiro SG, Stahel RA.
    Br J Cancer; 1994 Feb 15; 69(2):247-52. PubMed ID: 8297722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beta 1 integrin expression on human small cell lung cancer cells.
    Feldman LE, Shin KC, Natale RB, Todd RF.
    Cancer Res; 1991 Feb 15; 51(4):1065-70. PubMed ID: 1705164
    [Abstract] [Full Text] [Related]

  • 19. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
    Poola I, Graziano SL.
    J Exp Clin Cancer Res; 1998 Jun 15; 17(2):165-73. PubMed ID: 9700577
    [Abstract] [Full Text] [Related]

  • 20. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K.
    Oncogene; 1989 Jan 15; 4(1):45-50. PubMed ID: 2536917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.